Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure

Hypertension

Volumn 41, Issue 4, 2003, Pages 968-977

  Kacimi, Rachid ^a   Gerdes, Anthony Martin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

G proteins; Heart failure; Hypertension, genetic; Hypertrophy; Signal transduction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE; RHO FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL MODEL; GENETIC MODEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HYPERTENSION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DISEASE PROGRESSION; GTP-BINDING PROTEINS; HEART FAILURE, CONGESTIVE; HETEROTRIMERIC GTP-BINDING PROTEINS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MONOMERIC GTP-BINDING PROTEINS; MYOCYTES, CARDIAC; PHOSPHOPROTEIN PHOSPHATASE; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION;

EID: 0037390060     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000062465.60601.CC     Document Type: Article

References (49)

1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med. 1995;46:455-466.
2. Bristow MR. Why does the myocardium fail? Insights from basic science. Lancet. 1998;352(suppl 1):8-14.
3. Swynghedaw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
4. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100:999-1008.
5. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling concepts and clinical implications: a consensus paper from an international forum of cardiac remodeling. J Am Coll Cardiol. 2000;35:562-582.
6. Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin. Circ Res. 1999;84:633-646.
7. Chien KR. Stress pathways and heart failure. Cell. 1999;98:555-558.
8. Molkentin J, Dorn G II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Ann Rev Physiol. 2001;63:391-426.
9. Post GR, Brown JH. G protein coupled receptors and signal pathways regulating growth responses. FASEB J. 1996;10:741-749.
10. cp rat model: a genetic model of congestive heart failure: In: Singal PK, Dixon IMC, Beamish RE, Dhalla NS, eds. Mechanisms of Heart Failure. Boston, Mass: Kluwer Academic Publishers; 1995:91-106.
11. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension. 1998;32:753-757.
12. Tamura T, Said S, Gerdes AM. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension. 1999;33:676-680.
13. cp) rats. Am J Physiol. 1997;273:H228-H233.
14. Gerdes AM, Onodera T, Wang X, McCune SA. Myocyte remodeling during the progression to failure in rats with hypertension. Hypertension. 1996;28:609-614.
15. Tamura T, Said S, Harris J, Lu W, Gerdes AM. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system. Circulation. 2000;102:253-259.
16. Anderson KM, Eckhart AD, Wilette RN, Koch WJ. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension. 1999;33:402-407.
17. Radin MJ, Holycross BJ, Sharkey LC, Shiry L, McCune SE. Gender modulates activation of the renin-angiotensin and endothelin system in hypertension and heart failure. J Appl Physiol. 2002;92:935-940.
18. Kacimi R, Richalet JP, Crozatier B. Differential regulation of adenosinergic and muscarinic receptors in rat heart exposed to chronic hypoxia. J Appl Physiol. 1993;75:1123-1128.
19. Kacimi R, Moalic JM, Aldashev A, Vatner DE, Richalet JP, Crozatier B. Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia. Am J Physiol. 1995;269:H1865-H1873.
20. Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1β-stimulated inducible nitric oxide synthase pathways in cardiac myocytes. Circulation. 1997;96:1937-1943.
21. Kacimi R, Chentoufi J, Honbo N, Long CS, Karliner JS. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: role of p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res. 2000;46:139-150.
22. Makino N, Sugano M, Otsuka S, Hata T. Molecular mechanisms of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension. 1997;30:796-802.
23. Lefkowitz RJ. G protein-coupled receptors and receptor kinase: from molecular biology to potential therapeutic application. Nat Biotechnol. 1996;14:283-286.
24. Yi X P, Gerdes AM, Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart failure prone rats. Hypertension. 2002;39:1058-1063.
25. Matsumoto T, Ryoji o, Oshima T, Matsuura H, Sueda T, Kajiyama G, Kambe M. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patient with heart failure. Cardiovasc Res. 2000;46:73-81.
26. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E. Regulation of chamber localization, and subtype distribution of angiotensin receptors in human heart. Circulation. 1995;91:1461-1471.
27. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T. Angiotensin type 2 receptor is up regulated in human heart failure with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res. 1998;83:1035-1046.
28. Bowz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin-induced cardiomyocyte hypertrophy. Hypertension. 1995;28:635-640.
29. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2-receptor research in the cardiovascular system. Hypertension. 1999;33:613-621.
30. Opie LH, Sack MN. Enhanced Ang II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes. Circ Res. 2001;88:654-658.
31. Ichihara S, Senbomatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation. 2001;104:346-351.
32. Gilman AG. G proteins: transducers of receptor-generated signals. Ann Rev Biochem. 1987;56:615-649.
33. 13 stimulates gene expression and increases cell size in cultured neonatal rat ventricular myocytes. Cardiovasc Res. 1999;42:140-148.
34. Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res. 2000;86:1019-1023.
35. Gutkind JS. Cell Growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 1998;17:1331-1342.
36. Ju H, Zhao S, Tappia PS, Panagia V, Dixon IM. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation. 1998;10:892-899.
37. Jalili T, Takeishi Y, Song G, Ball NA, Howles G, Walsh RA. PKC translocation without changes in Galphaq and PLC-beta protein abundance in cardiac hypertrophy and failure. Am J Physiol. 1999;277: H2298-H2304.
38. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 1990;348:125-132.
39. Coso OA, Chiariello M, Yu JC, Teramoto H, and Crespo P, Xu N, Miki T, Gutkind JS. The small GTP-binding proteins RAC1, and CDc42 regulate the activity of the JNK/SAPK signaling pathways. Cell. 1995;81:1137-1146.
40. Mukai Y, Shimokawa H, Motoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J. 2001;15:1062-1064.
41. Kyriakis JM, Avrush J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:808-859.
42. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
43. Boygovitch MA. Signaling via stress-activated mitogen-activated protein kinases in the cardiovascular system. Cardiovasc Res. 2000;45:826-842.
44. Takeishi Y, Huang Q, Abe JI, Glassman M, Che W, Lee JD, Kawakatsu H, Lawrence EG, Hoit BD, Berk BC, Walsh RA. SRC and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure overload: comparison with acute mechanical stretch. J Mol Cell Cardiol. 2001;33:1637-1648.
45. Aoyagi T, Izumo S. Hemodynamic overload-induced activation of myocardial mitogen-activated protein kinases in vivo: augmented responses in young spontaneously hypertensive rats and diminished responses in aged Fisher 334 rats. Hypertension. 2001;37:52-57.
46. Lemke LE, Bloem LJ, Fouts R, Esterman M, Sandusky G, Vlahos CJ. Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. J Mol Cell Cardiol. 2001;33:1527-1540.
47. Takeishi Y, Huang Q, Abe JI, Che W, Lee JD, Kawakatsu H, Hoit BD, Berk BC, Walsh RA. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res. 2002;53:131-137.
48. Izumi Y, Kim S, Tomohisa M, Yamanaka S, Hiroshi I. Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats. Hypertension. 1998;31:50-56.
49. Yu P, Asico LD, Eisner GM, Hopfer U, Felder RA, Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension. 2000;36:1053-1058.